Penn Researchers Help Unravel Mysteries of Pancreatic Cancer’s Resistance to Standard Therapies

LW Newsfeed

Pancreatic cancer has long been one of the hardest to treat.

Now, in a new study, researchers at the Perelman School of Medicine at the University of Pennsylvania have illuminated one of this cancer’s major resistance mechanisms: a form of inflammation that is triggered by the tumor in response to treatment and helps keep tumor cells alive.

Blocking this inflammation after radiation therapy brought a significant improvement in survival in a mouse model of the disease. Read more . . .

image_printPrint Page